Modulation of the Angiogenic Phenotype of Normal and Systemic Sclerosis Endothelial Cells by Gain-Loss of Function of Pentraxin 3 and Matrix Metalloproteinase 12

被引:42
作者
Margheri, Francesca
Serrati, Simona
Lapucci, Andrea
Chilla, Anastasia
Bazzichi, Laura [2 ]
Bombardieri, Stefano [2 ]
Kahaleh, Bashar [3 ]
Calorini, Lido
Bianchini, Francesca
Fibbi, Gabriella [1 ]
Del Rosso, Mario [1 ]
机构
[1] Univ Florence, Dept Expt Pathol & Oncol, I-50134 Florence, Italy
[2] Univ Pisa, Pisa, Italy
[3] Med Coll Ohio, Toledo, OH 43699 USA
来源
ARTHRITIS AND RHEUMATISM | 2010年 / 62卷 / 08期
关键词
PLASMINOGEN-ACTIVATOR RECEPTOR; FIBROBLAST GROWTH FACTOR-2; IN-VITRO ANGIOGENESIS; UROKINASE RECEPTOR; EXPRESSION; ANGIOSTATIN; CANCER; RECOGNITION; PROTEOLYSIS; REDUCTION;
D O I
10.1002/art.27522
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Studies have shown that in systemic sclerosis (SSc) endothelial cells, overproduction of matrix metalloproteinase 12 (MMP-12) and pentraxin 3 (PTX3) is associated with defective angiogenesis. This study was undertaken to examine whether overexpression of the relevant molecules could inhibit angiogenesis of normal microvascular endothelial cells (MVECs), and whether silencing of these molecules in SSc MVECs could restore the lost angiogenic properties of the cells in vitro and in vivo. Methods. Transient transfection of MVECs with human MMP12 and PTX3 was performed by electroporation. Silencing of MMP12 and PTX3 was obtained by treatment with small interfering RNA, and treatment effects were validated by Western blotting with specific antibodies and a fluorimetric assay. In vitro cell migration and capillary morphogenesis were studied on Matrigel substrates. In vivo angiogenesis was studied using a Matrigel sponge assay in mice. Results. Transfection of MMP12 and PTX3 in normal MVECs resulted in loss of proliferation, invasion, and capillary morphogenesis in vitro, attributed to truncation of the urokinase-type plasminogen activator receptor by MMP12 and to the anti-fibroblast growth factor 2/anti-vascular endothelial growth factor activity of PTX3. These effects were particularly evident in mixed populations of transfected normal MVECs (50% transfected with MMP12 and 50% with PTX3). Silencing of the same molecules in SSc MVECs increased their invasion in Matrigel. Single-gene silencing did not increase the capillary morphogenesis of SSc MVECs, whereas double-gene-silenced cells showed a burst of capillary tube formation. Culture medium of silenced SSc MVECs stimulated angiogenesis in assays of Matrigel sponge invasion in mice. Conclusion. Overexpression of either MMP12 or PTX3 in normal MVECs blunts their angiogenic properties. Loss of function of MMP12 and PTX3 in SSc MVECs restores the ability of the cells to produce capillaries in vitro and induces vascularization in vivo on a Matrigel sponge.
引用
收藏
页码:2488 / 2498
页数:11
相关论文
共 31 条
  • [1] Andolfo A, 2002, THROMB HAEMOSTASIS, V88, P298
  • [2] Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2
    Billottet, C
    Janji, B
    Thiery, JP
    Jouanneau, J
    [J]. ONCOGENE, 2002, 21 (53) : 8128 - 8139
  • [3] uPAR-uPA-PAI-l interactions and signaling: A vascular biologist's view
    Binder, Bernd R.
    Mihaly, Judit
    Prager, Gerald W.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2007, 97 (03) : 336 - 342
  • [4] Carmeliet P, 2000, J PATHOL, V190, P387
  • [5] Sema4D induces angiogenesis through met recruitment by Plexin B1
    Conrotto, P
    Valdembri, D
    Corso, S
    Serini, G
    Tamagnone, L
    Comoglio, PM
    Bussolino, F
    Giordano, S
    [J]. BLOOD, 2005, 105 (11) : 4321 - 4329
  • [6] Raynaud's phenomenon and the role of capillaroscopy
    Cutolo, M
    Grassi, W
    Cerinic, MM
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (11): : 3023 - 3030
  • [7] Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis
    D'Alessio, S
    Fibbi, G
    Cinelli, M
    Guiducci, S
    Del Rosso, A
    Margheri, F
    Serratì, S
    Pucci, M
    Kahaleh, B
    Fan, PS
    Annunziato, F
    Cosmi, L
    Liotta, F
    Matucci-Cerinic, M
    Del Rosso, M
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (10): : 3275 - 3285
  • [8] Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells
    Dell'Era, P
    Belleri, M
    Stabile, H
    Massardi, ML
    Ribatti, D
    Presta, M
    [J]. ONCOGENE, 2001, 20 (21) : 2655 - 2663
  • [9] Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis
    Distler, O
    Distler, JHW
    Scheid, A
    Acker, T
    Hirth, A
    Rethage, J
    Michel, BA
    Gay, RE
    Müller-Ladner, U
    Matucci-Cerinic, M
    Plate, KH
    Gassmann, M
    Gay, S
    [J]. CIRCULATION RESEARCH, 2004, 95 (01) : 109 - 116
  • [10] VEGF: an update on biological and therapeutic aspects
    Farrara, N
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2000, 11 (06) : 617 - 624